Abbott Ordered to Turn Over E-mails in Government Probe

April 13, 2010
Looking into whether the drugmaker illegally marketed a neurological drug

A federal judge has ordered Abbott Laboratories to hand over thousands of e-mails in connection with a government investigation into whether the drugmaker illegally marketed a neurological drug.

Abbott has refused two subpoena requests from the attorney general for the Western District of Virginia, calling the request "overly burdensome." The attorney general requested all e-mails by three executives, including Chief Executive Miles White, sent between 1996 and 2008.

The attorney general is investigating whether Abbott promoted its anti-seizure drug Depakote for aggression in seniors, an unapproved use.

U.S. judge Samuel Wilson rejected Abbott's arguments in documents posted online, and ordered the company to produce the e-mails.

Copyright 2010 The Associated Press

Popular Sponsored Recommendations

The Customer Is Still King! Improving Service to Maximize Revenue, Reduce Costs, Boost Loyalty!

Feb. 26, 2024
Join this webinar to learn how to deliver frictionless customer service (CX) amid changes to supply chains, unpredictable buyer demand, and the adoption of automation and AI.

S&OP Optimization: Data-driven Strategies to Achieve Sustainable Profitability

Feb. 6, 2024
Through collaborative S&OP, manufacturers can balance demand and supply effectively, optimize resources, and capitalize on emerging market opportunities. Learn how to maximize...

Getting the Most From Integrated Business Planning: A Collection

Feb. 22, 2024
Through this series of articles, you’ll get a definitive look at the power of IBP and how to leverage that power.

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!